Publication | Closed Access

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment

Gene TherapiesVascular DiseaseTranslational MedicineAngiogenesisCardiovascular DiseaseAngiogenic Gene TherapyAtherosclerosisVascular BiologyBiomedical EngineeringNeovascularizationPhase 2MedicineCardiologyCardiovascular Translational Research